We are live on ! Find out more
ERNA icon

Eterna Therapeutics
ERNA

5 hedge funds and large institutions have $5.69M invested in Eterna Therapeutics in 2014 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

4% more capital invested

Capital invested by funds: $5.46M → $5.69M (+$228K)

0% more funds holding

Funds holding: 5 → 5 (0)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
5
Holders Change
–
Holders Change %
0%
% of All Funds
0.14%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
GPCM
Granite Point Capital Management
Massachusetts
-$490K
2
Bank of America
Bank of America
North Carolina
-$111K
Name Holding Trade Value Shares
Change 		Change in
Stake
EAM
1
Eagle Asset Management
Florida
$2.27M – – –
MHP
2
Manatuck Hill Partners
Connecticut
$1.22M – – –
GPCM
3
Granite Point Capital Management
Massachusetts
$729K -$490K -1 -50%
Renaissance Technologies
4
Renaissance Technologies
New York
$481K – – –
SONJCPFA
5
State of New Jersey Common Pension Fund A
New Jersey
$325K – – –
Vanguard Group
6
Vanguard Group
Pennsylvania
$239K – – –
Dimensional Fund Advisors
7
Dimensional Fund Advisors
Texas
$155K – – –
BIT
8
BlackRock Institutional Trust
California
$81K – – –
OC
9
Oppenheimer & Co
New York
$72K – – –
Geode Capital Management
10
Geode Capital Management
Massachusetts
$32K – – –
Goldman Sachs
11
Goldman Sachs
New York
$30K – – –
Northern Trust
12
Northern Trust
Illinois
$23K – – –
U
13
UBS
Switzerland
$20K – – –
Morgan Stanley
14
Morgan Stanley
New York
$4K – – –
Bessemer Group
15
Bessemer Group
New Jersey
$1K – – –
Manulife (Manufacturers Life Insurance)
16
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$4 – – –
Bank of America
17
Bank of America
North Carolina
– -$111K – –

ERNA Hedge Fund Activity: Q1 2014 in Review

5 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in Eterna Therapeutics (ERNA) for Q1 2014, worth a combined $5.69M — up 4.2% from $5.46M a quarter earlier.

Fund positioning in ERNA was balanced in Q1 2014: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 1 trimmed.

The largest seller was Granite Point Capital Management, cutting an estimated $490K.

  • 5 institutional investors held Eterna Therapeutics (ERNA) as of Q1 2014, unchanged from Q4 2013.
  • Funds reported $5.69M of Eterna Therapeutics stock for Q1 2014, up 4.2% quarter-over-quarter.
  • 0 funds opened new Eterna Therapeutics positions in Q1 2014 and 0 closed out.
  • The largest Eterna Therapeutics seller in Q1 2014 was Granite Point Capital Management, an estimated $490K sold.

Based on aggregated 13F filings for Q1 2014.